Jeff Yass’s Tenaya Therapeutics TNYA Stock Holding History

Jeff Yass’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54K	Buy	73,000 +2,900	+4%	+$2.2K	﹤0.01%	12802
2026 Q1	$48.4K	Sell	70,100 -29,800	-30%	-$22K	﹤0.01%	12643
2025 Q4	$70.9K	Sell	99,900 -50,900	-34%	-$69.2K	﹤0.01%	11622
2025 Q3	$244K	Buy	+150,800	New	+$152K	﹤0.01%	10568
2024 Q3	–	Sell	-10,500	Closed	-$32.5K	–	13051
2024 Q2	$32.5K	Sell	10,500 -4,100	-28%	-$16.9K	﹤0.01%	11541
2024 Q1	$76.4K	Buy	+14,600	New	+$69.9K	﹤0.01%	11359
2023 Q3	–	Sell	-13,100	Closed	-$76.9K	–	12987
2023 Q2	$76.9K	Buy	+13,100	New	+$76.1K	﹤0.01%	11127

Other funds holding TNYA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's TNYA Position: Q2 2026 in Review

Jeff Yass increased its Tenaya Therapeutics (TNYA) stake by 5.4% in Q2 2026, buying an estimated $12.6K and bringing the position to 325,316 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #11559.

Jeff Yass first reported a position in TNYA in Q4 2022 and has held it in 14 quarters since. The position peaked at $575K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

Jeff Yass held 325,316 shares of Tenaya Therapeutics worth $240K as of Q2 2026.
Jeff Yass bought 16,544 Tenaya Therapeutics shares in Q2 2026, an estimated $12.6K.
Tenaya Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11559 holding.
Jeff Yass first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 14 quarters since.
Jeff Yass's Tenaya Therapeutics position peaked at $575K in Q3 2025.
101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.